rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The project was undertaking by Qilu Hospital of Shandong University and other 13 well-known
hospitals in China. In order to report the efficacy and safety of Recombinant Human
thrombopoietin combining with Dexamethasone for the treatment of adults with primary immune
thrombocytopenia (ITP), compared to High-dose Dexamethasone therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Shandong University
Collaborators:
Anhui Medical University China Medical University, China Shandong Provincial Hospital Shenzhen Second People's Hospital The Affiliated Hospital of the Chinese Academy of Military Medical Sciences The First Affiliated Hospital of Dalian Medical University Zhejiang Provincial Hospital of TCM